GLP-1 nanomedicine alleviates gut inflammation

GLP-1-SSM or SSM 15 nmol/100 μl was administered intraperitoneally/day for 7 days to control and DSS treated C57BL/6J male mice. At the end of the study the markers of inflammation were analyzed in distal colonic mucosa.172